| Issue Date | Title | Involved Person(s) |
| 14-Feb-2024 | Suicide rates and prescription of antidepressants | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
| 2024 | Suicidality emerging from rapid Venlafaxine discontinuation | Kostic, Milutin; Plöderl, Martin; Hengartner, Michael; Buzejic, Jelena |
| Sep-2023 | Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al. : concerning harm-benefit ratio in a recent trial about Escitalopram for generalized anxiety disorder | Plöderl, Martin; Horowitz, Mark A.; Hengartner, Michael P. |
| 2022 | Suizidpräventive Effekte von Ketamin und Esketamin | Plöderl, Martin; Hengartner, Michael P.; Volkmann, Constantin |
| 17-Dec-2021 | Effect of the FDA black box suicidality warnings for antidepressants on suicide rates in the USA : signal or noise? | Plöderl, Martin; Hengartner, Michael Pascal |
| 8-Nov-2021 | Learning about the course of suicidal behavior but not about the effects of SSRIs | Plöderl, Martin; Hengartner, Michael Pascal |
| 25-Nov-2020 | Did the introduction and increased prescribing of antidepressants lead to changes in long-term trends of suicide rates? | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
| Nov-2019 | Wirken Antidepressiva bei schweren Depressionen besser als bei leichten? | Hengartner, Michael Pascal; Plöderl, Martin |
| 2018 | Starting two antidepressants to prevent suicide : a potentially dangerous recommendation? | Hengartner, Michael Pascal; Plöderl, Martin |
